LigaChem Biosciences, Inc.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 2006-05-01
- Employees
- 147
- Market Cap
- -
- Website
- http://www.legochembio.com
An Open-label, Single Dose, Parallel Design, Phase 1 Clinical Study of LCB01-0371
Phase 1
Terminated
- Conditions
- First Posted Date
- 2015-08-20
- Last Posted Date
- 2016-04-08
- Lead Sponsor
- LigaChem Biosciences, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT02529241
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Multiple Ascending Dose Study for LCB01-0371
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-04-29
- Last Posted Date
- 2014-11-17
- Lead Sponsor
- LigaChem Biosciences, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01842516
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study
- First Posted Date
- 2012-03-15
- Last Posted Date
- 2014-11-17
- Lead Sponsor
- LigaChem Biosciences, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT01554995
- Locations
- 🇰🇷
Asan Medical Center, Seoul,, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath